06/18/2026 | Press release | Distributed by Public on 06/18/2026 14:12
Item 5.07. Submission of Matters to a Vote of Security Holders.
The annual meeting of stockholders (the "Annual Meeting") of Guardant Health, Inc. (the "Company") was held on June 17, 2026.
All of the nominees for director listed in Proposal 1 in the Company's Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 28, 2026 (the "Proxy Statement"), were elected to serve on the Company's board of directors by the following vote:
| Name of Nominee | Votes For | Votes Withheld | Broker Non-Votes | |||||||||
|
Ian Clark |
70,526,891 | 37,916,548 | 7,714,711 | |||||||||
|
Manuel Hidalgo Medina |
81,925,123 | 26,518,316 | 7,714,711 | |||||||||
Proposal 2 in the Proxy Statement, a proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026, was approved by the following vote:
|
Votes For |
Votes Against |
Abstentions |
||
| 115,899,030 | 15,250 | 243,870 |
Proposal 3 in the Proxy Statement, a proposal to approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, was not approved by the following vote:
|
Votes For |
Votes Against |
Abstentions |
Broker Non-Votes |
|||
| 98,236,639 | 9,905,190 | 301,610 | 7,714,711 |
Proposal 4 in the Proxy Statement, a proposal to determine, on an advisory (non-binding) basis, the frequency of future stockholder advisory votes regarding the compensation of the Company's named executive officers, was determined as follows:
|
Votes Cast for One Year |
Votes Cast For Two Years |
Votes Cast for Three Years |
Abstentions |
Broker Non-Votes |
||||
| 107,997,996 | 14,303 | 265,413 | 165,727 | 7,714,711 |